CD19 and autoimmune disease: Since CD19 plays a pivotal role in BCR signaling and its overall expression pattern from pro-B-cells until the terminal differentiation to plasma cells (Figure 8), it is not surprising that abnormal CD19 expression on B-cells is associated with autoimmune diseases and development of malignancies [122,124].